Last reviewed · How we verify

NCT03229304

Prediction of Postpartum Hemorrhage With Uterine Artery Doppler Measurement

Completed Last updated 25 July 2017
What this trial tests

trial in Postpartum Hemorrhage in 800 participants. Completed in 1 June 2017.

Timeline
1 May 2016
Primary endpoint
1 May 2017
1 June 2017

Quick facts

Lead sponsorKanuni Sultan Suleyman Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment800
Start date1 May 2016
Primary completion1 May 2017
Estimated completion1 June 2017
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Who can join

Adults 18 to 40, female only, with Postpartum Hemorrhage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate the uterine artery doppler just before labour in term low risk pregnancies. And to investigate with this measurement if investigators could foreseen the amount of postpartum hemorrhage looking at decreased in the hematocrit values.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Postpartum Hemorrhage

Currently open trials in the same condition.

Other Kanuni Sultan Suleyman Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03229304.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing